These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23897632)

  • 1. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
    Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
    Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.
    Riganti C; Salaroglio IC; Pinzòn-Daza ML; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Couraud PO; Bosia A; Ghigo D; Schiffer D
    Cell Mol Life Sci; 2014 Feb; 71(3):499-516. PubMed ID: 23771630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
    Schaich M; Kestel L; Pfirrmann M; Robel K; Illmer T; Kramer M; Dill C; Ehninger G; Schackert G; Krex D
    Ann Oncol; 2009 Jan; 20(1):175-81. PubMed ID: 18687982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
    Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
    Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F; Pan Q; Yu H; Yue X
    J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells.
    Munoz JL; Walker ND; Scotto KW; Rameshwar P
    Cancer Lett; 2015 Oct; 367(1):69-75. PubMed ID: 26208431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.
    Pinzón-Daza ML; Salaroglio IC; Kopecka J; Garzòn R; Couraud PO; Ghigo D; Riganti C
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1258-69. PubMed ID: 24896565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of Cytoskeletal Protein Adducin 3 and CD133 in Neurospheres and a Temozolomide-resistant Subclone of Glioblastoma.
    Poon MW; Zhuang JT; Wong ST; Sun S; Zhang XQ; Leung GK
    Anticancer Res; 2015 Dec; 35(12):6487-95. PubMed ID: 26637861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
    Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
    Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.
    Tezcan G; Tunca B; Bekar A; Preusser M; Berghoff AS; Egeli U; Cecener G; Ricken G; Budak F; Taskapılıoglu MO; Kocaeli H; Tolunay S
    Cell Mol Neurobiol; 2014 Jul; 34(5):679-92. PubMed ID: 24691539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
    Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
    Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
    Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
    Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
    Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
    Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.
    Ciceroni C; Bonelli M; Mastrantoni E; Niccolini C; Laurenza M; Larocca LM; Pallini R; Traficante A; Spinsanti P; Ricci-Vitiani L; Arcella A; De Maria R; Nicoletti F; Battaglia G; Melchiorri D
    Cell Death Differ; 2013 Mar; 20(3):396-407. PubMed ID: 23175182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma.
    Cheng ZX; Yin WB; Wang ZY
    Int J Mol Med; 2017 Nov; 40(5):1307-1314. PubMed ID: 28901390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
    Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C
    Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
    Chou CW; Wang CC; Wu CP; Lin YJ; Lee YC; Cheng YW; Hsieh CH
    Neuro Oncol; 2012 Oct; 14(10):1227-38. PubMed ID: 22946104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.